Plasma adrenomedullin relation with Doppler-derived dP/dt in patients with congestive heart failure

Maria-Aurora Morales1, Silvia Del Ry, Umberto Startari

  • 1Cardiology and Cardiovascular Biochemistry Laboratory, CNR Institute of Clinical Physiology, Pisa, Italy. morales@ifc.cnr.it

Clinical Cardiology
|April 7, 2006
PubMed

Insights

Increased adrenomedullin (AM) levels correlate with left ventricular (LV) dysfunction severity in heart failure (HF) patients. This finding may help characterize HF progression independently of ejection fraction.

Area of Science:

  • Cardiology
  • Biomarkers
  • Heart Failure Research

Background:

  • Elevated circulating adrenomedullin (AM) is linked to heart failure (HF).
  • AM is a potential biomarker for cardiac dysfunction.

Purpose of the Study:

  • To investigate the association between AM levels and left ventricular (LV) function in HF patients.
  • To evaluate AM as a marker for LV dysfunction severity using echo-Doppler methods.

Main Methods:

  • Measured plasma AM, B-type natriuretic peptide (BNP), and N-terminal proBNP in 55 HF patients and 20 controls.
  • Calculated dP/dt (rate of pressure rise) from mitral regurgitation jet Doppler tracings.
  • Assessed patients across NYHA functional classes I, II, and III.

Main Results:

  • AM levels were significantly higher in HF patients than controls and increased with NYHA class.
  • dP/dt showed a stronger correlation with AM (r=0.582) than with BNP or NT-proBNP.
  • AM levels differed significantly based on dP/dt cut-offs predicting event-free survival.

Conclusions:

  • Increased AM, combined with reduced contractility, may help characterize LV dysfunction severity in HF.
  • AM's predictive value appears independent of baseline LV ejection fraction.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Assessing Blood pressure using a doppler ultrasound01:19

Assessing Blood pressure using a doppler ultrasound

To obtain accurate blood pressure measurements in clinical settings, especially when traditional methods are insufficient, healthcare professionals utilize the Doppler ultrasound technique. This method uses high-frequency sound waves to detect blood flow within the arteries, which is crucial for patients with conditions that complicate circulatory system assessment.
Pre-Procedural Guidelines for Doppler Ultrasound Blood Pressure Assessment:
Preparation of Equipment:
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.